Cetrorelix Acetate Patent Expiration
Cetrorelix Acetate is Used for preventing premature LH surges in women undergoing controlled ovarian stimulation. It was first introduced by Emd Serono Inc
Cetrorelix Acetate Patents
Given below is the list of patents protecting Cetrorelix Acetate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cetrotide | US6319192 | Method for the treatment of fertility disorders |
Apr 23, 2019
(Expired) | Emd Serono Inc |
| Cetrotide | US6863891 | Oligopeptide lyophilisate, their preparation and use |
Feb 22, 2014
(Expired) | Emd Serono Inc |
| Cetrotide | US7605121 | Oligopeptide lyophilisate, their preparation and use |
Feb 22, 2014
(Expired) | Emd Serono Inc |
Cetrorelix Acetate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List